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Abstract Dietary boron intake is associated with
reduced prostate and lung cancer risk and increased
bone mass. Boron is absorbed and circulated as boric
acid (BA) and at physiological concentrations is a
reversible competitive inhibitor of cyclic ADP ribose,
the endogenous agonist of the ryanodine receptor
calcium (Ca?2) channel, and lowers endoplasmic
reticulum (ER) [Ca2?]. Low ER [Ca2?] has been
reported to induce ER stress and activate the eIF2a/
ATF4 pathway. Here we report that treatment of DU-
145 prostate cells with physiological levels of BA
induces ER stress with the formation of stress granules
and mild activation of eIF2a, GRP78/BiP, and ATF4.
Mild activation of eIF2a and its downstream tran-
scription factor, ATF4, enables cells to reconfigure
gene expression to manage stress conditions and mild
activation of ATF4 is also required for the differen-
tiation of osteoblast cells. Our results using physio-
logical levels of boric acid identify the eIF2a/ATF
pathway as a plausible mode of action that underpins
the reported health effects of dietary boron.
Keywords Boron  Boric acid  eIF2a  ATF4 
DU-145 cells
Abbreviations
BA Boric acid
cADPR Cyclic ADP ribose
ER Endoplasmic reticulum
TIA-1 T-cell intracellular antigen-1
Grp78 Binding immunoglobulin protein (BiP) also
known as 78 kDa glucose-regulated protein
ATF4 Activating transcription factor 4
SG Stress granule
ISR Integrated stress response
Introduction
Human boron intake is affected by both regional
geology, which contributes to its concentration in
drinking water and agricultural soils, and by local
preferences for boron rich fruits, vegetables, nuts,
legumes and plant based beverages such as coffee,
wine and fruit juice (Rainey and Nyquist 1998;
Barranco et al. 2007a, b). Higher intake of boron is
associated with a lower risk of prostate cancer and
volume in men, lung cancer in women, and bone mass
in animals (Mahabir et al. 2008; Korkmaz et al. 2007).
In humans, 83–98 % of dietary boron is excreted in
urine in 96 h and is distributed as boric acid (BA) to all
tissues (WHO 1998). Cellular studies at physiological
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concentrations of BA were made possible by the
development of a procedure to deplete BA from cell
culture media (Bennett et al. 1999). In healthy men
blood BA concentrations range from below a detect-
able limit of 4.7 lM B (48.5 lg B/g wet blood) in low
boron regions to 350 lM B (3,600 lg B/g wet blood)
in boron mine workers (Bolt et al. 2012). BA is also a
developmental and reproductive toxin with a lowest
observed adverse effect level (LOAEL) for testicular
damage in rats reported at 620 lM B (Ku et al. 1993;
Chapin et al. 1997). The U.S. Environmental Protec-
tion Agency set a reference dose (RfD) at 0.2 mg B/
kg/d (EPA 2004). BA inhibits the proliferation of
LNCaP and DU-145 prostate cancer cells in a dose-
dependent manner within the physiological range
(Barranco and Eckhert 2004). To identify a functional
molecular target of BA in the absence of a stable
radioactive boron isotope we based our approach on
the knowledge that BA interacts with NAD? (Johnson
and Smith 1976; Kim et al. 2003, 2004). CD38, a
multifunctional enzyme in the plasma membrane,
converts extracellular NAD? into cyclic ADP ribose
(cADPR), the only known agonist of the ryanodine
receptor calcium (Ca2?) channel. We identified cAD-
PR as a molecular target of BA and demonstrated that
physiological levels of BA inhibit cADPR-activated
ER Ca2? release within seconds of treatment and
reduce ER luminal Ca?2 concentrations ([Ca?2]ER)
(Henderson et al. 2009; Kim et al. 2006).
High [Ca?2]ER is required for protein folding in the
ER and provides a steep gradient between the ER
(100–500 lM) and cytoplasm (20–100 nM) that
enables rapid Ca?2 signaling (Berridge 1997, 2002).
Treatment with thapsigargin, a plant sesquiterpene
lactone, inhibits the ATP-dependent ER Ca?2 pump
(SERCA) resulting in lower [Ca?2]ER and accumula-
tion of unfolded and misfolded proteins (Conn 2011;
Deniaud et al. 2008). Unfolded proteins sequester
glucose-regulated protein (GRP78/BiP) away from the
luminal domain of the ER transmembrane protein,
double stranded RNA-activated protein kinase (PKR)-
like ER kinase (PERK) (Hendershot 2004; Shen et al.
2004). The release of GRP78/BiP enables PERK to
dimerize and phosphorylate the serine 51 residue of
eukaryotic initiation factor 2a (eIF2a). Phosphoryla-
tion of eIF2a mediates the integrated stress response
(ISR) which maintains cellular homeostasis under mild
ER stress and redirects transcription and translation to
a subset of proteins that include the transcription factor
ATF4 which is usually down-regulated in models of
human prostate cancer (So et al. 2009). Non-toxic
levels of BA have been reported to activate phosphor-
ylation of eIF2a in mammalian cells (Henderson and
Eckhert 2006; Henderson 2009) and teratogenic levels
have been reported to activate it in yeast (Uluisik et al.
2011; Narotsky et al. 1998; WHO 1998). Here we
report that treatment of DU-145 prostate cancer cells
with physiological concentrations of BA causes mild
ER stress with ER expansion, the formation of
cytoplasmic stress granules, and activation of the
eIF2a/ATF4 integrated stress response (ISR).
Materials and methods
Chemicals
Boric acid, Tris, NaCl, MgCl2, sucrose, DTT, methanol,
and DMSO were purchased from Sigma-Aldrich (St.
Louis, MO). Glutaraldehyde, cacodylic acid, lead citrate,
and uranyl acetate were purchased from Electron Micros-
copy Supplies (Hatfield, PA). Paraformaldehyde was
purchased from Affymetrix/USB Corporation (Cleve-
land, OH). TritonX-100, Tween-20, NP40, and cyclohex-
imide were purchased from Fisher Scientific (Pittsburg,
PA). BSA and thapsigargin were purchased from Santa
Cruz Biotechnologies (Santa Cruz, CA). Fetal Bovine
Serum (FBS) was purchased from Gibco-Life Sciences
(Grand Island, NY). Protease and phosphatase inhibitors
were purchased from Calbiochem (San Diego, CA).
Cell culture
DU-145 prostate cancer cells, obtained from the Amer-
ican Type Culture Collection (Manassas, VA), were
maintained in RPMI Media 1640 (Gibco-Life Technol-
ogies, Grand Island, NY) supplemented with 10 % FBS,
penicillin (100 U/ml), streptomycin (100 lg/ml), and L-
glutamine (200 mM) (Gemini Bio-Products, Sacra-
mento, CA). Cells were plated on 10 or 15 cm plates
(Corning Life Sciences, Corning, NY) and incubated at
37 C in a humidified chamber containing 5 % CO2 and
95 % air and grown to 80 % confluency. Our procedure
to remove boron from media has been previously
described (Bennett et al. 1999). All treatment groups in
the present study used media that had been stripped of
boron by shaking with 2 g of Amberlite IRA 743
exchange resin (Sigma-Aldrich) for 12 h at 4 C.
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Transmission electron microscopy (TEM)
Cells were grown on plastic cover slips (Nalgene,
Rochester, NY) to no more than 80 % confluency and
treated with BA-supplemented complete media at con-
centrations of 0, 10, 50, and 250 lM for 24 h, followed by
fixation with 2 % glutaraldehyde in 0.1 M sodium
cacodylate buffer. Samples were dehydrated with increas-
ing concentrations of ethanol followed by infiltration and
embedding in RL White acrylic resin (Ted Pella, Redding,
CA). The resin embedded cells were sectioned in 100 nm
slices and placed on copper grids. The sections were
counter stained with 2 % aqueous uranyl acetate at 57 C
for 1 h followed by 4 % lead citrate staining for 1 min.
Imaging by TEM was performed using a JEOL 100CX
transmission electron microscope.
Immunofluorescent microscopy
DU-145 cells were grown to 80 % confluency on glass
cover slips (Fisher Scientific, Pittsburg, PA) and treated
with either BA-free media (0), BA-free media supple-
mented with BA, or 1 lM thapsigargin. Cells stained for
TIA-1 were first fixed with 4 % paraformaldehyde in
PBS and permeabilized with 0.5 % TritonX-100 in
PBS. Fixed cells were blocked with 10 % FBS in PBS
overnight. Next, they were incubated in a humidity
chamber with anti-TIA-1 (Santa Cruz Biotechnology)
monoclonal antibody at concentrations of 1:50 followed
by secondary FITC at 1:100. Coverslips were mounted
with a mixture of Vectashield with 40,6-diamidino-2-
phenylindole (Vector Laboratories, Burlingame, CA)
and regular HardSet Vectashield (Vector Laboratories)
mounting mediums at 1:5 respectively. Images were
captured with an Olympus DP72 camera (Olympus
America, Center Valley, PA) connected to an Olympus
BX51 fluorescence microscope (Olympus America)
using an Olympus UIS2 UPlanFLN 100X/1.30 OilPh3
objective (Olympus America) and FITC and DAPI
filters. Either Olympus DP2-BSW (Olympus America)
or Adobe Photoshop (Adobe Systems Incorporated, San
Jose, CA) software was used to merge and crop images.
Immunoblot analysis
DU-145 cells grown on 15 cm plates (Corning) to
80 % confluency were treated with BA-free media (0)
or BA-free media supplemented with BA, 1 lM
thapsigargin, or DMSO positive control vehicle for
varying time points. Cells were washed with ice cold
phosphate buffer solution (PBS) supplemented with
0.1 % Tween (PBST) prior to adding 100 ll radio
immuno-precipitation assay (RIPA) lysis buffer. Cell
lysates were scraped from plates using a spatula
(Corning) and passed through a 23 gauge needle
(BD, Franklin Lakes, NJ) 8–10 times on ice. The
protein was quantitated using the Coomassie Plus
Protein Assay (Thermo-Scientific, Waltham, MA).
Aliquots of 30–35 lg protein were run on a 4–12 %
gradient TGX SDS-PAGE (Bio-Rad, Hercules, CA) at
200 V for 30 min along with a molecular weight ladder
(Bio-Rad). Protein was transferred to a nitrocellulose
membrane in transfer buffer with 20 % methanol at
40 V for 1.5 h. Membranes were blocked in 3 % BSA
with 37.5 mM Tris (pH 8.8), 125 mM NaCl, and 0.1 %
Tween 20 for at least 4 h. Following blocking, the
membranes were incubated with the primary antibody
for 1 h in PBST or 3 % BSA blocking solution, washed
in PBST, and incubated with the appropriate secondary
antibody with a HRP tag, followed by washing three
times with PBST. The membranes were exposed to
ECL Plus (Amersham/GE Healthcare, Pittsburg, PA)
for 2–5 min and imaged using a Typhoon 9410
Variable Mode Imager (Amersham). Densitometry
was performed using ImageQuant 5.2 software
(Molecular Dynamics, Pittsburg, PA). All secondary
antibodies were purchased from Santa Cruz Biotech-
nologies (Santa Cruz, CA). The following primary
antibodies from Santa Cruz Biotechnology were used:
TIA-1 (goat polyclonal), Grp78/BiP (mouse monoclo-
nal), Actin (goat polyclonal), GAPDH (mouse mono-
clonal) and ATF4 (rabbit polyclonal). The eIF2a
(rabbit polyclonal) and ph-eIF2a (rabbit polyclonal)
were purchased from Cell Signaling (Danvers, MA).
Taqman real time PCR (RT-PCR)
DU-145 cells were grown on 10 cm plates (Corning)
to 80 % confluency at least 24 h prior to treatment.
Cells were treated with BA and analyzed at various
time points. RNA was isolated from cells using an
RNeasy mini kit (Qiagen, Valencia, CA). Total RNA
(2 lg) was reverse transcribed using Superscript III
Reverse Transcriptase (Invitrogen) with random hex-
amer primers (Life Technologies) at a final volume of
20 ll at 25 C, 10 min (10:00); 50 C, 45:00; and
70 C, 15:00. Applied Biosystems (ABI, Foster City,
CA) Taqman predesigned assays were used for all
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genes as well as GAPDH as a control internal
housekeeping gene. Plates were read by a 7500 Fast
Real Time PCR System using the 7500 Fast System
Software v1.4.0 (ABI). Quantitation of gene expres-
sion levels were calculated from a standard curve
created from reactions containing a combination of
cDNA from all treatments for each gene.
Cell cycle analysis
Flow cytometry was performed to determine if BA caused
a shift in cell cycle to the G1 phase. DU-145 cells were
treated with 0 and 50 lM BA for 24 h. The cells were
washed with PBS, scraped from the plate with a rubber
policeman, centrifuged for 5 min at 1,200 rpm, and
resuspended in 1 ml of DNA staining hypotonic propidi-
um iodide solution (1 mg/ml sodium citrate, 0.3 %
tritonX100, 100 lg/ml propidium iodide, 20 lg/ml ribo-
nuclease A). The cells were incubated for 30 min followed
by cell cycle analysis using a FACS Calibur Flow
Cytometer with Modfit LT 3.0 software for data analysis.
Analysis of each sample was performed on greater than
10,000 events and coefficients of variation less than 5 %.
Statistical analysis
All immunoblot were analyzed using the unpaired
Student’s t test. All time points represent 3–6 replicates.
ImageJ software (NIH, Bethesda, MD) was used for
immunofluorescence quantitation. Cells with clear
borders between the nucleus and cytoplasm were
selected for analysis. The intensity of areas of equal
size in the nucleus and cytoplasm was quantified using
the histogram tool in RGB mode. RT-PCR data points
represent 3–6 replicates and were analyzed using the
unpaired Student’s t-test.
Results
BA causes dose-dependent changes in ER
morphology
Light microscopy analysis of BA treated DU-145 cells
showed cell flattening (Barranco and Eckhert 2006),
therefore we were interested in knowing how this
morphological change manifested at the ultrastruc-
tural level. We used TEM on DU-145 cells treated for
24 h with 0, 10, 50 or 250 lM BA. The results show a
dose-dependent increase in ER expansion, cytoplas-
mic granularity and cytoplasmic vacuole formation
(Fig. 1).
BA induces phosphorylation of eIF2a
and the formation of cytosolic stress granules
Cells respond to changes in their environment by
reprogramming translation to adapt to the new condi-
tions (Kawai et al. 2004). eIF2a is the regulatory
subunit of the large ternary complex, eIF2–GTP–
tRNAi Met, which positions the initiator methionine at
Fig. 1 BA induces ER vacuolization and expansion in DU-145
cells. TEM images of DU-145 cells treated for 24 h with 0, 10,
50, and 250 lM BA (n = 3). Cells exhibited a dose-dependent
swelling and vacuolization of the ER, (N nucleus, ER
endoplasmic reticulum). White boxes indicate magnified area
shown on the right
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the first codon of mRNA to commence translation and
protein synthesis. Phosphorylation of eIF2a on serine
51 inhibits the formation of the complex, thus
inhibiting global translation allowing cells to recover
from ER stress (Zoll et al. 2002). We observed an
increase in phosphorylation of eIF2a from 1 to 3 h
following treatment of DU-145 cells with 50 lM BA
(Fig. 2a). We used thapsigargin as positive control
since it induces ER stress by decreasing ER luminal
Ca2?. Thapsigargin also significantly activated phos-
phorylation of eIF2a in DU-145 cells at 24 h (Fig. 2a).
The absence of eIF2–GTP–tRNAi Met results in
eIF2/eIF5-deficient, ‘stalled’ 48S pre-initiation com-
plex (Kedersha et al. 2002). The eIF2/eIF5-deficient
pre-initiation complexes and their associated mRNA
transcripts are routed to cytoplasmic stress granules
(SG) in a process that requires the RNA-binding
proteins T-cell intracellular antigen-1 (TIA-1) and
TIAR (Anderson and Kedersha 2002). TIA-1 normally
resides in the nucleus of unstressed cells but under
stress conditions is recruited into SGs. Nearly 90 % of
TIA-1 and about 50 % of cytoplasmic poly(A) RNA
and poly(A)-binding protein-1 is recruited into SGs
(Anderson and Kedersha 2002; Kedersha et al. 2002).
We treated cells with 10 lM BA or thapsigargin as a
positive control and used a polyclonal antibody to
TIA-1 to positively identify cytoplasmic granules as
SG. TIA-1 translocation from the nucleus began to
occur 15 min after treatment and reached a maximum
by 1 h (Fig. 3). This correlated with the timing of 1 h
maximum for eIF2a phosphorylation (Fig. 2a).
BA treatment increases GRP78/BiP
Glucose-regulated protein binds to and maintains the
transmembrane sensor PERK in an inactive form
(Hendershot 2004; Pfaffenbach and Lee 2011).
GRP78/BiP protein levels significantly increased in
DU-145 cells treated with 50 lM BA for 6, 12 and
24 h post-treatment (Fig. 2b).
BA induces ATF4
Phosphorylation of eIF2a activates synthesis of ATF4,
a transcription factor in the highly conserved ISR that
enables cells to adapt to changing environmental
conditions. We used polyclonal antibodies to measure
ATF4 protein and observed an increase at 24 h in cells
treated with 10 lM BA (Fig. 2c). The results of a dose
response study showed the expression of ATF4
mRNA was increased by treatment with 10, 50 and
100 lM BA, but not 1 lM BA (Fig. 2d). A time
course study showed the expression of ATF4 mRNA
in cells treated with 10 lM BA was higher at 30 min, 1
and 2 h post treatment (Fig. 2e). ATF4 mRNA levels
returned to normal in the interval between 4 and 12 h
and increased again at 24 h.
Cell cycle percentages were not affected by a 24 h
treatment of BA
Flow cytometry analysis following a 24 h treatment
with 50 lM BA had little impact on the cell cycle. The
percent of cells treated with 0 or 50 lM BA were: G1
phase 50.59 ± 0.75 and 51.21 ± 0.62 %, S phase
13.09 ± 1.16 and 15.15 ± 0.38 %, G2 phase 32.09 ±
0.46 and 31.53 ± 0.18 % respectively (Fig. 4). The
2 % shift in S phase (p value = 0.03) was so small it was
doubtful it had biological meaning. This result is
consistent with previous reports demonstrating that
BA does not cause a biologically significant effect on the
cell cycle (Barranco and Eckhert 2004; Bradke et al.
2008). We did not observe an apoptotic cell population
after BA treatment.
Discussion
A review conducted by the Institute of Medicine of the
available data on dietary boron concluded it was
beneficial but the molecular mechanisms underpin-
ning its positive effects were unknown (IOM 2001).
We describe in this article molecular responses of DU-
145 human prostate cancer cells that follow treatment
with physiological concentrations of BA. We draw
several conclusions from our experimental results.
First, BA causes a dose- and time-dependent
expansion of the ER with formation of cytoplasmic
SGs (Figs. 1, 2). We positively identified cytosolic
granules as SGs using an antibody to the tumor
suppressor TIA-1, a classic biomarker of SG forma-
tion (Kedersha et al. 1999). TIA-1, with TIAR, act
downstream of ph-eIF2a to promote the recruitment of
untranslated mRNAs into SGs which are essential in
regulating developmental and stress-responsive path-
ways at the level of alternative pre-mRNA splicing
and mRNA translation (Kedersha et al. 1999; Buchan
and Parker 2009; Bauer et al. 2012). This allows for
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Fig. 2 BA induces the eIF2a/ATF4 pathway. a 50 lM BA
treated for 24 h induced phosphorylation of eIF2a in DU-145
cells at 1, and 3 h of treatment (n = 3–5). DU-145 cells treated
with 1 lM thapsigargin (Tg) or DMSO (DM) for 1 h, n = 3.
b DU-145 cells treated with 50 lM BA for 0, 0.5, 3, 6, 12 and
24 h. GAPDH was used as an internal loading control.
Translation of GRP78/BiP increased in cells treated at 6–24 h,
(n = 3–4). c Treatment of DU-145 cells with 10 lM BA for
24 h caused a significant increase in ATF4. d DU-145 cells were
treated with different doses of BA for 24 h and ATF4 mRNA
levels measured using real-time PCR (n = 3–6). Significant
increases in mRNA were observed at 10, 50 and 100 lM BA.
e A time course study following treatment of DU-145 cells with
10 lM BA showed significantly higher ATF4 mRNA levels at
0.5, 1, 2, and 24 h (n = 3–6). Significance differences from 0
concentration or time are shown and represented using
*p \ 0.05, **p \ 0.01 and ***p \ 0.001. Error bars represent
standard deviations
138 Biometals (2015) 28:133–141
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temporary confinement of mRNA transcripts and
reduces their ability to interact with other molecules
while preventing their degradation (Buchan and
Parker 2009). Activation of TIA-1 in HeLa cells has
been shown to prevent cell proliferation, tumor
growth, and invasion (Izquierdo et al. 2011). Our
observation that BA activates TIA-1 in DU-145 cells
suggests this is part of the mechanism that underpins
BA’s chemopreventive and biological activity. The
ability of BA to activate TIA-1 provides insight into a
potential mechanism underlying BA stimulated
increases in TNFa in human fiberblasts and pigs
(Armstrong and Spears 2003; Benderdour et al. 1998).
TIA-1 is a component of a regulatory complex that
binds to an adenine/uridine-rich element in the 30UTR
of TNFa mRNA. TIA-1 binding represses TNFa
mRNA translation under non-stress conditions, but
releases it during ER stress (Gueydan et al. 1999;
Piecyk et al. 2000). Our results suggest BA may
induce TNFa by causing TIA-1 to translocate from the
nucleus to stress granules in the cytoplasm, thus
removing its repressive effect (Benderdour et al. 1998;
Armstrong and Spears 2003).
Second, BA increases eIF2a phosphorylation and
BiP/GRP78 translation. BiP/GRP78 inactivates PERK
and is the major ER Ca2? storage protein and is
regulated by luminal Ca2? levels (Lievremont et al.
1997). BIP/GRP78 is released and PERK is activated
and phosphorylates eIF2a when luminal Ca2? levels
fall, (Lievremont et al. 1997). Our results show
Fig. 3 BA induces formation of TIA-1 positive stress granules.
10 lM BA induced formation of TIA-1 positive stress granules in
DU-145 cells at 0.25, 0.5, and 1 h, indicated by TIA-1 protein
(green) moving out of the nucleus (blue) with BA treatment. 1 lM
thapsigargin (Tg) was used as a positive control, (n = 6–24 cells).
All time points showed a significant increase. Pictures are
representative of results. Significance differences were repre-
sented as *p\ 0.05, **p \ 0.01, and ***p\ 0.001 and error
bars represent standard deviations. (Color figure online)
Fig. 4 The cell cycle was not significantly altered by BA
treatment. Flow cytometry analysis was conducted a 24 h
treatment with 0 or 50 lM BA. The percent of cells treated with
0 or 50 lM BA were: G1 phase 50.59 ± 0.75 and
51.21 ± 0.62 %, S phase 13.09 ± 1.16 and 15.15 ± 0.38 %,
G2 phase 32.09 ± 0.46 and 31.53 ± 0.18 % respectively,
(n = 3). The 2 % shift in S phase was of doubtful biological
significance. Standard deviation error bars were plotted, but are
too close to the bar graph to visualize
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phosphorylation of eIF2a is a time-dependent
response that peaks 1 h post-treatment which is within
the time frame reported for BA to decrease ER Ca2? in
DU-145 cells (Henderson et al. 2009).
Third, BA upregulates the transcription factor, ATF4.
Phosphorylation of eIF2a increases upstream open
reading frame (uORF) mediated translation of bone
related activating transcription factor 4 (ATF4)(Vattem
and Wek 2004). The ph-eIF2a/ATF4 pathway is highly
conserved from yeast to mammals and has been named
the ISR because it is a target of many different types of
environmental stresses (Harding et al. 2003). Our
observation that BA induces mild activation of ATF4
in prostate cancer cells may provide insight for under-
standing how boron supplementation increases bone
mass and strength (Hunt 1996; Armstrong and Spears
2003; Nielsen and Stoecker 2009). Mild activation of
ATF4 regulates osteogenesis during development and
postnatally regulates bone remodeling and the osteoblast
specific gene osteocalcin (Wang et al. 2012). Parathyroid
hormone mediates its functions in part by regulating
binding of ATF4 to osteocalcin which is an essential
regulator of endochondral bone formation and for the
reversal of bone loss and (Danciuk et al. 2012).
In summary, previous work has shown that BA is a
competitive inhibitor of cADPR induced Ca2? release
from the ryanodine receptor, and decreases ER Ca?2
(Henderson et al. 2009). In this paper we demonstrate
that mild ER stress and activation of the ISR, both
known to be initiated by ER Ca2? depletion, occur
following treatment of DU-145 prostate cancer cells
with physiological concentrations of BA. In the
context of the literature, our present findings suggest
mild ER stress with mild activation of the eIF2a/ATF
pathway may underpin the anticarcinogenic and bone
strengthening effects of boron.
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